Document Detail


Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.
MedLine Citation:
PMID:  18223669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Starting out from a brief description of the determinants of coronary blood flow (perfusion, pressure, extravascular compression, autoregulation, metabolic regulation, endothelium-mediated regulation and neurohumoral regulation) the present review highlights the overwhelming importance of metabolic regulation such that coronary blood flow is increased at increased heart rate under physiological circumstances and the overwhelming importance of extravascular compression such that coronary blood flow is decreased at increased heart rate through reduction of diastolic duration in the presence of severe coronary stenoses. The review goes on to characterize the role of heart rate in the redistribution of regional myocardial blood flow between a normal coronary vascular tree with preserved autoregulation and a poststenotic vasculature with exhausted coronary reserve. When flow is normalized by heart rate, there is a consistent close relationship of regional myocardial blood flow and contractile function for each single cardiac cycle no matter whether or not there is a coronary stenosis and what the actual blood flow is. beta-Blockade improves both flow and function along this relationship. When the heart rate reduction associated with beta-blockade is prevented by pacing, alpha-adrenergic coronary vasoconstriction is unmasked and both flow and function are deteriorated. Selective heart rate reduction, however, improves both flow and function without any residual negative effect such as unmasked alpha-adrenergic coronary vasoconstriction or negative inotropic action.
Authors:
G Heusch
Related Documents :
18258419 - Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of e...
11708839 - Myocyte apoptosis and reduced sr gene expression precede the transition from chronicall...
7192859 - Independent regulation of atrial coronary blood flow by atrial contraction rate in cons...
15860399 - Elevated plasma homocysteine level in slow coronary flow.
571929 - Effect of graded coronary constriction on the flow reserve in regional myocardium in dog.
17574929 - Coronary reactivity, homocysteine and methylenetetrahydrofolate reductase gene variatio...
410229 - Systemic and regional blood flow during epidural anesthesia with epinephrine in the rhe...
1629029 - In vivo studies of unlabeled and radioiodinated rhodamine-123.
2824619 - A rapid percoll technique for the purification of human basophils.
Publication Detail:
Type:  Journal Article; Review     Date:  2008-01-28
Journal Detail:
Title:  British journal of pharmacology     Volume:  153     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-04-14     Completed Date:  2008-08-12     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1589-601     Citation Subset:  IM    
Affiliation:
Institute for Pathophysiology, University of Essen Medical School, Essen, Germany. gerd.heusch@uk-essen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology
Animals
Anti-Arrhythmia Agents / pharmacology
Benzazepines / pharmacology
Coronary Circulation / drug effects*
Heart Rate / drug effects*
Humans
Myocardial Ischemia / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Benzazepines; 155974-00-8/ivabradine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative study on transduction and toxicity of protein transduction domains.
Next Document:  Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.